Oral Session 3-15C AML: Gemonic Analysis

[OS3-15C-2] Genomic analysis of therapy-related myeloid neoplasms and tracking of the founder clone by ctDNA

Kanya Kondoh¹, Kazuaki Yokoyama^1,2, Nozomi Yusa³, Mika Ito¹, Eigo Shimizu⁴, Sousuke Nakamura¹, Miho Ogawa¹, Tomomi Takei¹, Asako Kobayashi¹, Rika Kasajima⁵, Yuka Wada⁶, Rui Yamaguchi⁷, Seiya Imoto⁵, Tokiko Nagamura⁶, Kaoru Uchimaru⁸, Satoru Miyano^4,5, Arinobu Tojo^1,2 (1.Division of Molecular Therapy, IMSUT, University of Tokyo, 2.Department of Hematology/Oncology, IMSUT Hospital, University of Tokyo, 3.Department of Applied Genomics, IMSUT Hospital, University of Tokyo, 4.Laboratory of DNA Information Analysis, IMSUT, University of Tokyo, 5.Health Intelligence Center, IMSUT, University of Tokyo, 6.Department of Cell Processing and Transfusion, IMSUT, University of Tokyo, 7.Division of Cancer Systems Biology, Aichi Cancer Center Research Institute, 8.Graduate School of Frontier Sciences, University of Tokyo)